急性白血病患者血管性血友病因子抗原检测的临床价值

王卫国; 马芳; 李玉云; 张夏; 郭进京; 王伟伟; 王卫国; 马芳; 李玉云; 张夏; 郭进京; 王伟伟

[1]

Kang YS,Kim HS,Park HJ,et al.Clinical characteristics of 75 patients with leukemia cutis[J].Med Sci,2013,28(4):614-619.

[2]

Mackinnon B,Deighan CJ,Norrie J,et al.The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis[J].Clin Nephrol,2005,63(3):173-180.

[3]

许文荣,王建中.临床血液学检验[M].北京:人民卫生出版社,2012:329-331.

[4]

王小超,蒙兰青.急性白血病患者血栓前状态的研究[J].广西医科大学学报,2010,27(2):275-276.

[5]

肖芳芳,胡锴勋,郭梅,等.初诊急性白血病凝血指标异常及其临床意义探讨[J].中国实验血液学杂志,2013,21(2):300-304.

[6]

Hatzipantelis ES,Athanassiou-Metaxa M,Gombakis N,et al.Thrombomodulin and von Willebrand factor:relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia[J].Acta Haematol,2011,125(3):130-135.

[7]

孙秀丽,方美云.急性白血病患者乳酸脱氢酶变化的临床意义 [J].白血病·淋巴瘤,2011,20(2):95-97.

[8]

Yao X,Huang J,Zhong H,et al.Targeting interleukin-6 in inflammatory autoimmune diseases and cancers[J].Pharmacol Ther,2013,141(2):125-139.